类有机物
生物
疾病
机制(生物学)
多囊肾病
计算生物学
药品
药物发现
肾
神经科学
生物信息学
药理学
内科学
遗传学
医学
哲学
认识论
作者
Tracy Tran,Cheng Song,Trang Nguyen,Shun-Yang Cheng,Jill A. McMahon,Rui Yang,Qiuyu Guo,Bálint Dér,Nils O. Lindström,Daniel C.-H. Lin,Andrew P. McMahon
出处
期刊:Cell Stem Cell
[Elsevier BV]
日期:2022-07-01
卷期号:29 (7): 1083-1101.e7
被引量:88
标识
DOI:10.1016/j.stem.2022.06.005
摘要
Summary
Human pluripotent stem-cell-derived organoids are models for human development and disease. We report a modified human kidney organoid system that generates thousands of similar organoids, each consisting of 1–2 nephron-like structures. Single-cell transcriptomic profiling and immunofluorescence validation highlighted patterned nephron-like structures utilizing similar pathways, with distinct morphogenesis, to human nephrogenesis. To examine this platform for therapeutic screening, the polycystic kidney disease genes PKD1 and PKD2 were inactivated by gene editing. PKD1 and PKD2 mutant models exhibited efficient and reproducible cyst formation. Cystic outgrowths could be propagated for months to centimeter-sized cysts. To shed new light on cystogenesis, 247 protein kinase inhibitors (PKIs) were screened in a live imaging assay identifying compounds blocking cyst formation but not overall organoid growth. Scaling and further development of the organoid platform will enable a broader capability for kidney disease modeling and high-throughput drug screens.
科研通智能强力驱动
Strongly Powered by AbleSci AI